Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Gossamer Bio Enters into Option Agreement To Acquire Respira Therapeutics And Its Lead Candidate, RT234 For Pulmonary Hypertension; Gossamer To Issue 2.5M Shares In Connection With Signing And Shareholders Will Be Eligible For Milestones

Author: Benzinga Newsdesk | September 25, 2025 07:32am

Posted In: GOSS